All News about Nls Pharmaceutics Ltd
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/24/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3860.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/23/image24.jpeg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13265.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/25/image15.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/22/image9.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/22/image11.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/22/image29.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
NLS Pharmaceutics Ltd. Announces Closing of US$4.4 Million Registered Direct Offering
April 26, 2022
From NLS Pharmaceutics AG
Via AccessWire
Topics
Regulatory Compliance
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
From NLS Pharmaceutics AG
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_413.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_553.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27160.png?v=0)
NLS Pharmaceutics to Participate in 2022 BIO CEO & Investor Conference
February 11, 2022
From NLS Pharmaceutics AG
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.